These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 8928891

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T, Wada A, Ohnishi M, Tsutamoto T, Fujii M, Matsumoto T, Takayama T, Wang X, Kurokawa K, Kinoshita M.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [Abstract] [Full Text] [Related]

  • 4. Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure.
    Fukai D, Wada A, Tsutamoto T, Kinoshita M.
    Jpn Circ J; 1998 Aug; 62(8):604-10. PubMed ID: 9741739
    [Abstract] [Full Text] [Related]

  • 5. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
    Borgeson DD, Grantham JA, Williamson EE, Luchner A, Redfield MM, Opgenorth TJ, Burnett JC.
    Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
    Stevens TL, Rasmussen TE, Wei CM, Kinoshita M, Matsuda Y, Burnett JC.
    J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
    Stevens TL, Burnett JC, Kinoshita M, Matsuda Y, Redfield MM.
    J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
    [Abstract] [Full Text] [Related]

  • 12. Limitations of compensation by endogenous atrial natriuretic peptide in heart failure.
    Tsutamoto T, Kanamori T, Wada A, Miyauchi N, Murata T, Kinoshita M.
    Jpn Circ J; 1992 May; 56(5):489-93. PubMed ID: 1318429
    [Abstract] [Full Text] [Related]

  • 13. Possible regulation of renin release by ANP in dogs with heart failure.
    Kanamori T, Wada A, Tsutamoto T, Kinoshita M.
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2281-7. PubMed ID: 7611478
    [Abstract] [Full Text] [Related]

  • 14. Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
    Supaporn T, Sandberg SM, Borgeson DD, Heublein DM, Luchner A, Wei CM, Dousa TP, Burnett JC.
    Kidney Int; 1996 Nov; 50(5):1718-25. PubMed ID: 8914042
    [Abstract] [Full Text] [Related]

  • 15. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M, Wada A, Tsutamoto T, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Wang X, Kinoshita M.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [Abstract] [Full Text] [Related]

  • 16. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure.
    Mizuno O, Onishi K, Dohi K, Motoyasu M, Okinaka T, Ito M, Isaka N, Nakano T.
    Am J Cardiol; 2001 Oct 15; 88(8):863-6. PubMed ID: 11676948
    [Abstract] [Full Text] [Related]

  • 17. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M, Woods LL, Hohimer AR, Shiota T, Matsuda Y, Davis LE.
    Pediatr Res; 1995 Nov 15; 38(5):722-8. PubMed ID: 8552440
    [Abstract] [Full Text] [Related]

  • 18. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
    Tsutamoto T, Kanamori T, Wada A, Kinoshita M.
    J Am Coll Cardiol; 1992 Sep 15; 20(3):541-6. PubMed ID: 1324959
    [Abstract] [Full Text] [Related]

  • 19. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.
    Matsumoto T, Wada A, Tsutamoto T, Omura T, Yokohama H, Ohnishi M, Nakae I, Takahashi M, Kinoshita M.
    Am J Physiol; 1999 Jun 15; 276(6):H1935-42. PubMed ID: 10362673
    [Abstract] [Full Text] [Related]

  • 20. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure.
    Ohte N, Cheng CP, Suzuki M, Little WC.
    J Pharmacol Exp Ther; 1999 Nov 15; 291(2):589-95. PubMed ID: 10525076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.